TGA
New sexual dysfunction warnings added to antidepressants’ PI
Health professionals are advised to consider current or previous antidepressant use in patients reporting sexual dysfunction Updated product information documents (PIs) for nine antidepressant medications will include warnings relating to …
TGA continues cannabis advertising clampdown
Regulator targets medicinal cannabis pharmacy over alleged unlawful advertising The Therapeutic Goods Administration (TGA) has issued nine infringement notices totalling $164,460 to Victorian pharmacy, Better Leaf Pty Ltd, over alleged unlawful …
Government acts on compounding concerns
Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) …
TGA issues SSSI for abatacept
Pharmacists authorised to substitute Orencia 125mg/mL products to deal with shortages The Therapeutic Goods Administration (TGA) has issued a Serious Scarcity Substitution Instrument (SSSI) in response to shortages of both …
GSK to bolster Shingrix supply
TGA grants temporary approval for the use of overseas-sourced Shingrix in Australia GSK is set to supply Shingrix vaccines registered in Hong Kong to the Australian market for patients eligible …
Abatacept shortage hits earlier than forecast
Pharmacists urged to advise patients with prescriptions for Orencia (abatacept) to speak to their specialists as shortages hit Bristol-Myers Squibb Australia (BMS) has advised the Therapeutic Goods Administration (TGA) that …
Nurse fined following botox bust
Victorian nurse handed infringement notices totalling more than $7,500 over the alleged importation of unapproved prescription-only products The Therapeutic Goods Administration (TGA) has issued two fines to a Victoria-based nurse …
Dark Horse warning from TGA
Australians urged not to access medicines from “unknown overseas websites” after sildenafil found in imported product Consumers are being advised to take any remaining capsules of an imported medication called …
Vyvanse still scarce
TGA may have been premature in declaring supply shortages of Vyvanse are “resolved”, a pharmacist says Securing supplies of various strengths of ADHA medication, Vyvanse (lisdexamfetamine dimesilate) is continuing to …
Vyvanse shortage ‘resolved’
TGA declares supply issues impacting ADHD medication Vyvanse to be “resolved” Takeda Pharmaceuticals Australia is reporting that supply shortages are no longer impacting its Vyvanse (lisdexamfetamine dimesilate) capsules. Shortages had impacted …
‘Stiff’ syringe warning for Panadol Children
Parents are being urged to dispose of dosing syringes provided with 14 batches of an infant paracetamol product Haleon Australia has issued a Product Defect Correction for 14 batches of …
Shortage on the way
The TGA says it is investigating a solution to a predicted abatacept shortage The Therapeutic Goods Administration has released a statement saying that it is aware that shortages of both Orencia …